𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1

✍ Scribed by M. D. Miramar; M. T. Calvo; A. Rodriguez; A. Antón; F. Lorente; E. Barrio; A. Herrero; J. Burriel; A. García de Jalón

Publisher
Springer US
Year
2008
Tongue
English
Weight
241 KB
Volume
112
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA1 and BRCA2 mutation analysis in bre
BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland
✍ Magdalena Perkowska; Izabela BroŻek; Barbara Wysocka; Karin Haraldsson; Therese 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for germline mutations in BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185), using a combination of protein truncation test, denaturing high-performance liquid chromatography and direct sequencing. Sixteen (27%)

Prevalence of BRCA1 genomic rearrangemen
Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations
✍ Simona Agata; Alessandra Viel; Lara Della Puppa; Laura Cortesi; Giusi Fersini; M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

The presence of genomic rearrangements of the BRCA1 gene in breast and/or ovarian cancer families has been intensively investigated in patients from various countries over the last years. A number of different rearrangements have been reported by several studies that clearly document the involvement

Novel germline BRCA1 and BRCA2 mutations
Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic
✍ Eva Machackova; Jiri Damborsky; Dalibor Valik; Lenka Foretova 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 3 views

## Communicated by Mark H. Paalman Germline mutations in breast cancer susceptibility genes, BRCA1 and BRCA2, are responsible for a substantial proportion of high-risk breast and breast/ovarian cancer families. To characterize the spectrum of BRCA1 and BRCA2 mutations, we screened Czech families w

Novel germline mutations in the BRCA1 an
Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families
✍ Mani T. Valarmathi; Meenakshi Sawhney; Suryanarayana S. V. Deo; Nootan K. Shukla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

The two major hereditary breast/ovarian cancer predisposition tumor suppressor genes, BRCA1 and BRCA2 that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are altered, or mutated in the germline. However, little is known abo

Germline mutations of BRCA1 and BRCA2 in
Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families
✍ Hio Chung Kang; Il-Jin Kim; Jae-Hyun Park; Hyuk-Jun Kwon; Yong-Jin Won; Seung Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2